EUVIMEDEuropean Health Evidence
Uhr 10/10Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations

Sonja Potrebic, Sarah Tanveer, Werner J. Becker, Rebecca Burch, Lara J. Cooke, Todd Fenton, Jeff J. Fletcher, Gillian L. Gordon Perue, Andrew D. Hershey, Jeffrey L. Jackson, Shirley Kessel, Elizabeth W. Loder, Mia T. Minen, Maryam Oskoui, Vijay K. Ramanan, Michelle Murren, Todd J. Schwedt, Stephen D. Silberstein, Don B. Smith, Kylie A. Botchway‐Doe, Heather M. Silsbee, Tamara Pringsheim

Headache: The Journal of Head and Face Pain · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract This practice guideline provides updated evidence‐based recommendations regarding the use of pharmacologic migraine prevention in adults. A multidisciplinary panel conducted a systematic review and developed practice recommendations following the process outlined in the 2017 edition of the American Academy of Neurology Clinical Practice Guideline Process Manual. The systematic review includes studies published through June 6, 2024, and is available in a companion publication. Recommendations are supported by structured rationales that integrate evidence from the systematic review, related evidence, principles of care, and inferences from evidence. Recommendations are provided on how to decide when it is appropriate to start a pharmacologic migraine preventive medication and how to decide which migraine preventive medication to start. Recommendations address decision making on appropriate choices of migraine preventive medications in specific situations and populations, including patients with fibromyalgia, obesity, or hypertension; considerations for older adults; treatment during pregnancy and lactation; sex‐related factors in choosing medications; and treatment for patients with medication overuse. Recommendations on assessment of treatment efficacy, adverse effects, and discontinuing migraine preventive medications are provided.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Sonja Potrebic, Sarah Tanveer, Werner J. Becker, Rebecca Burch, Lara J. Cooke, Todd Fenton, Jeff J. Fletcher, Gillian L. Gordon Perue, Andrew D. Hershey, Jeffrey L. Jackson, Shirley Kessel, Elizabeth W. Loder, Mia T. Minen, Maryam Oskoui, Vijay K. Ramanan, Michelle Murren, Todd J. Schwedt, Stephen D. Silberstein, Don B. Smith, Kylie A. Botchway‐Doe, Heather M. Silsbee, Tamara Pringsheim
Quelle
Headache: The Journal of Head and Face Pain
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0017-8748, 1526-4610
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Sonja Potrebic, Sarah Tanveer, Werner J. Becker, Rebecca Burch, Lara J. Cooke, Todd Fenton, Jeff J. Fletcher, Gillian L. Gordon Perue, Andrew D. Hershey, Jeffrey L. Jackson, Shirley Kessel, Elizabeth W. Loder, Mia T. Minen, Maryam Oskoui, Vijay K. Ramanan, Michelle Murren, Todd J. Schwedt, Stephen D. Silberstein, Don B. Smith, Kylie A. Botchway‐Doe, Heather M. Silsbee, Tamara Pringsheim (2026). Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.70199
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1 · Lizenz 2